Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

about

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

Item

http://www.wikidata.org/entity/Q37590133

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@en

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@nl

type

Item

label

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@en

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@nl

prefLabel

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@en

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@nl

P1476

Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.

@en

P2093

Bonnie Ghosh-Dastidar

http://www.w3.org/2001/XMLSchema#string

Glenn J Wagner

http://www.w3.org/2001/XMLSchema#string

Mary Slaughter

http://www.w3.org/2001/XMLSchema#string

P2860

The PHQ-9: validity of a brief depression severity measure

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.

What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review.

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression.

A prospective study of predictors of adherence to combination antiretroviral medication

The role of adherence in mediating the relationship between depression and health outcomes.

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

A closer look at depression and its relationship to HIV antiretroviral adherence.

Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

P304

91-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2325957416677121

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28084190

http://www.w3.org/2001/XMLSchema#string

P921

Uganda

antiretroviral drug

P932

5240801

http://www.w3.org/2001/XMLSchema#string